Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 9;2(10):nzy066.
doi: 10.1093/cdn/nzy066. eCollection 2018 Oct.

Substitution of Corn Starch with Resistant Starch Type 4 in a Breakfast Bar Decreases Postprandial Glucose and Insulin Responses: A Randomized, Controlled, Crossover Study

Affiliations

Substitution of Corn Starch with Resistant Starch Type 4 in a Breakfast Bar Decreases Postprandial Glucose and Insulin Responses: A Randomized, Controlled, Crossover Study

Eunice Mah et al. Curr Dev Nutr. .

Abstract

Background: Resistant starches type 4 (RS4) are chemically modified starches that are resistant to digestion by human enzymes.

Objective: We aimed to test our hypothesis that replacement of standard starch with RS4 in a baked breakfast bar would decrease postprandial glycemic and insulinemic responses in healthy adults.

Methods: In this double-blind, randomized crossover study, 21 healthy adults [10 men; 20-45 y old; BMI (kg/m2): 19.3-27.0] consumed a baked breakfast bar containing tapioca-based RS4 (Actistar 75330; Cargill, Inc.) or a macronutrient-matched control bar, delivering 32 g and 4 g of dietary fiber, respectively. Primary outcome was the incremental area under the curve (iAUC0-120 min) for postprandial capillary glucose. Other outcomes included postprandial serum insulin iAUC0-120 min, glucose and insulin maximum concentration (Cmax), and time to Cmax (Tmax).

Results: Median glucose iAUC0-120 min was 22% lower (P < 0.05) and median insulin iAUC0-120 min was 37% lower (P < 0.05) after consumption of the RS4 food compared with the control food. Glucose and insulin Cmax and Tmax were not significantly different (P > 0.05) between foods.

Conclusion: The results suggest that replacement of standard starch with tapioca-based RS4 is a practical approach for reducing available carbohydrate in products and achieving postprandial blood glucose management. This trial was registered at clinicaltrials.gov as NCT03239288.

Keywords: Actistar; clinical trial; fiber; human; resistant starch; tapioca.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
CONSORT diagram indicating sample sizes at each stage during the study. CONSORT, Consolidated Standards of Reporting Trials; ITT, intent to treat; PP, per protocol.
FIGURE 2
FIGURE 2
Capillary glucose (A) and serum insulin (B) concentrations in healthy adults (n = 21) who consumed a breakfast bar containing RS4 or a control bar that was matched for fat, protein, and total carbohydrate content, delivering 32 g and 4 g of dietary fiber, respectively. RS4, resistant starch type 4.

Similar articles

Cited by

References

    1. Raigond P, Ezekiel R, Raigond B. Resistant starch in food: a review. J Sci Food Agric 2015;95(10):1968–78. - PubMed
    1. Birt DF, Boylston T, Hendrich S, Jane JL, Hollis J, Li L, McClelland J, Moore S, Phillips GJ, Rowling M, et al. . Resistant starch: promise for improving human health. Adv Nutr 2013;4(6):587–601. - PMC - PubMed
    1. Charalampopoulos D, Wang R, Pandiella SS, Webb C. Application of cereals and cereal components in functional foods: a review. Int J Food Microbiol 2002;79(1–2):131–41. - PubMed
    1. Office of Nutrition and Food Labeling, Center for Food Safety and Applied Nutrition, Food and Drug Administration, US Department of Health and Human Services Science review of isolated and synthetic non-digestible carbohydrates. 2016. [Internet]. [cited 2018 Jan 30]. https://www.fda.gov/downloads/Food/LabelingNutrition/UCM529049.pdf.
    1. Al-Tamimi EK, Seib PA, Snyder BS, Haub MD. Consumption of cross-linked resistant starch (RS4XL) on glucose and insulin responses in humans. J Nutr Metab 2010:651063. - PMC - PubMed

Associated data